The FTC accused GoodRx, the prescription drug discount platform, of sharing sensitive health data with big tech companies.February 1, 2023Check out STAT+Sponsored By Adobe GoodRx leaked sensitive health information to Facebook and Google, FTC alleges The FTC accused GoodRx, the prescription drug discount platform, of sharing sensitive health data with big tech companies. By Mohana Ravindranath STAT+ | 6 things to know about Apellis' eye drug ahead of FDA decision Apellis Pharmaceuticals, the drug's maker, has expressed public confidence in the data supporting approval. Investors are more divided. By Adam Feuerstein STAT+ | Medicare Advantage insurers will score $2 billion gift thanks to limited audits A new rule will give a free pass to Medicare Advantage plans for any erroneous codes they submitted between 2011 and 2017. By Bob Herman and Tara Bannow Dumornay et. al., American Journal of Psychiatry MRI scans reveal disparate impact of poverty and other 'toxic stress' on brains of Black children The finding may help explain longstanding racial disparities in the prevalence of psychiatric disorders such as PTSD. By Usha Lee McFarling Opinion: Disruptive science is leaping forward, not limping along A study claiming that disruptive innovation in science has dramatically and mysteriously declined since 1945 has it wrong. By Juergen Eckhardt and George Church STAT+ | KKR veteran sets records with $3.9 billion health care fund Patient Square Capital closed on $3.9 billion for its fund, the largest inaugural fund for a new U.S.-based private equity firm. By Allison DeAngelis Alex Hogan/STAT STAT+ | New antidepressant study provides hints to Verily's future A small Phase 2 trial of a new antidepressant may hold clues to the direction of Verily, the high-profile Alphabet health tech spinout. By Matthew Herper and Casey Ross Opinion: Promises — and pitfalls — of ChatGPT-assisted medicine ChatGPT could assist with medical education and administrative tasks. But it isn't ready for clinical decision-making. By Rushabh H. Doshi and Simar S. Bajaj More around STATCheck out more exclusive coverage with a STAT+ subscriptionRead premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.Enjoying Daily Recap? Tell us about your experienceContinue reading the latest health & science news with the STAT appDownload on the App Store or get it on Google Play STAT, 1 Exchange Place, Boston, MA©2023, All Rights Reserved.I no longer wish to receive STAT emailsUpdate Newsletter Preferences • Contact Us • Advertise with Us • View in Browser
No comments